Ian Begley, SNY.tv | Twitter |
The NBA and NBPA agreed to suspend random player drug testing during the current moratorium to address concerns regarding the proximity of drug testers amid coronavirus fears and the sensitivity of drawing blood, SNY sources confirmed.
Players are customarily subjected to random drug testing over the course of the year, as part of the collective bargaining agreement.
Typically, a player will be tested roughly six times over the course of the year.
The league and the players association reached an agreement to table the testing while the league is on hiatus due to coronavirus. In theory, if a tester is infected with coronavirus, it could be passed along to a player.
Currently, the NBA season is suspended through April 12. ESPN reported that some owners expect the season to be off until mid-June.
Other stipulations agreed to between the league and the players association include: Teams are not permitted to engage in any group workouts or practices. Players and teams must coordinate individual workouts, whether they are at the practice facility or off-site. If multiple players are working out at the team facility at the same time, they need to use parts of the facility on an individual basis, such as one player and one coach working on the same basket or no more than one player using weight-training equipment at the same time.
The same coach or staff member will work with the same individual player consistently to limit exposure.
Yahoo! Sports first reported the suspension of random drug testing during the NBA moratorium.